BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3718099)

  • 1. Hypoprothrombinemia associated with cefamandole use in a rural teaching hospital.
    Bertino JS; Kozak AJ; Reese RE; Chiarello LA
    Arch Intern Med; 1986 Jun; 146(6):1125-8. PubMed ID: 3718099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillin.
    Jones PG; Strother SV; Rolston KV; Fainstein V; Bodey GP
    Arch Intern Med; 1986 Jul; 146(7):1397-9. PubMed ID: 3521526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoprothrombinaemia and bleeding during administration of cefamandole and cefoperazone. Report of three cases.
    Alitalo R; Ruutu M; Valtonen V; Lehtonen T; Pentikäinen PJ
    Ann Clin Res; 1985; 17(3):116-9. PubMed ID: 4051444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypoprothrombinemia and hemorrhagic diathesis caused by cefamandole].
    Cid M; Villalta J; Cardellach F; Ingelmo M
    Rev Clin Esp; 1985 Nov; 177(7):355. PubMed ID: 4081218
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired coagulopathy owing to parenteral cefamandole: renal failure as a predisposing factor.
    Chang JC
    Ann Clin Lab Sci; 1983; 13(5):418-24. PubMed ID: 6638932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoprothrombinemia due to cefamandole.
    Conraads VM; Demey HE; Heytens LG; Bossaert LL
    Klin Wochenschr; 1988 Dec; 66(23):1190-2. PubMed ID: 3062269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dangerous hypoprothrombinemic hemorrhage in antibiotic therapy].
    Stieger R; Baumgartner K; Neff U
    Helv Chir Acta; 1992 May; 58(6):775-8. PubMed ID: 1644592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cefamandole on hemostasis in patients undergoing hip replacement with heparin prophylaxis.
    Agnelli G; Guerciolini R; Boldrini F; Tonzani A; Della Torre P; Nenci GG; Del Favero A
    Chemioterapia; 1988 Dec; 7(6):396-9. PubMed ID: 3219752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoprothrombinemia associated with cefoperazone therapy.
    Mueller RJ; Green D; Phair JP
    South Med J; 1987 Nov; 80(11):1360-2. PubMed ID: 3686136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 1966-1988.
    Shevchuk YM; Conly JM
    Rev Infect Dis; 1990; 12(6):1109-26. PubMed ID: 2267487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected trimethoprim/sulfamethoxazole-induced hypoprothrombinemia.
    Cook DE; Ponte CD
    J Fam Pract; 1994 Dec; 39(6):589-91. PubMed ID: 7798864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoprothrombinaemia and bleeding associated with cephamandole.
    Clancy CM; Glew RH
    Lancet; 1983 Jan; 1(8318):250. PubMed ID: 6130288
    [No Abstract]   [Full Text] [Related]  

  • 13. Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
    Feld R; Rachlis A; Tuffnell PG; Duncan I; Moran L; Pinfold P; DeBoer G
    Arch Intern Med; 1984 May; 144(5):1005-10. PubMed ID: 6712393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost containment of the second-generation cephalosporins by prospective monitoring at a community teaching hospital.
    Williams RR; Gross PA; Levine JF
    Arch Intern Med; 1985 Nov; 145(11):1978-81. PubMed ID: 4062447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis.
    Park GH; Kim S; Kim MS; Yu YM; Kim GH; Lee JS; Lee E
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporin-induced hypoprothrombinemia: is the N-methylthiotetrazole side chain the culprit?
    Agnelli G; Del Favero A; Parise P; Guerciolini R; Pasticci B; Nenci GG; Ofosu F
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1108-9. PubMed ID: 3729364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan.
    Kaiser CW; McAuliffe JD; Barth RJ; Lynch JA
    Arch Surg; 1991 Apr; 126(4):524-5. PubMed ID: 1901205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug usage review of cefamandole at a teaching hospital.
    Zaremba CD; Bachand RL; Chow AW; Jewesson PJ
    Can J Hosp Pharm; 1988 Aug; 41(4):195-99, 214. PubMed ID: 10288851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
    Meeks SL; Abshire TC
    Haemophilia; 2008 Nov; 14(6):1159-63. PubMed ID: 19141155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation disorders associated with cefamandole: presentation of 2 cases].
    Cuxart M; Nogues X; Cuevas X; Aubia J
    Med Clin (Barc); 1987 Jun; 89(4):173-4. PubMed ID: 3626671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.